bromodeoxyuridine has been researched along with tegafur in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Hieda, S; Ishihara, M; Noguchi, M; Sawaguchi, K; Ueno, N; Yabushita, H | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nishimura, S; Yamaizumi, Z | 1 |
| De Clercq, E; Hoshi, A; Iigo, M; Nakajima, Y | 1 |
| Hanyu, F; Ide, H; Kobayashi, S; Muto, H; Nakagawa, M; Shimamura, Y; Takasaki, K; Tanaka, S; Yamada, A; Yamamoto, M | 1 |
| Fujiwara, M; Nakamura, H; Nakano, Y; Nonomura, N | 1 |
| Kudo, H; Maemura, M; Mitamura, T; Nakayama, T; Sakamoto, S; Sassa, S; Suzuki, S; Yoshimura, S | 1 |
7 other study(ies) available for bromodeoxyuridine and tegafur
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
[Experimental study on the effect of UFT with concomitant radiotherapy of uterine cervical cancer].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Division; Cell Line; Combined Modality Therapy; DNA Polymerase II; Female; Fluorouracil; Humans; Mice; Mice, Nude; Neoplasm Transplantation; Tegafur; Tumor Cells, Cultured; Uracil; Uterine Cervical Neoplasms | 1989 |
The antitumor potency of oral tegafur against adenocarcinoma 755 in mice is markedly enhanced by oral (E)-5-(2-bromovinyl)-2'-deoxyuridine.
Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Drug Synergism; Metabolic Clearance Rate; Mice; Neoplasms, Experimental; Tegafur | 1987 |
Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5-fluorouracil and ftorafur against adenocarcinoma 755 in mice.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cysteine; Drug Evaluation, Preclinical; Drug Synergism; Fluorouracil; Male; Mice; Tegafur | 1987 |
[Experiences with FT+BrdU+radiation therapy of esophageal cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Carcinoma, Squamous Cell; Combined Modality Therapy; Esophageal Neoplasms; Humans; Male; Middle Aged; Tegafur | 1987 |
Olfactory disturbances caused by the anti-cancer drug tegafur.
Topics: Adult; Animals; Bromodeoxyuridine; Cell Count; Epithelium; Female; Guinea Pigs; Humans; Male; Metaplasia; Middle Aged; Mitosis; Olfaction Disorders; Olfactory Mucosa; Olfactory Receptor Neurons; Proliferating Cell Nuclear Antigen; Smell; Tegafur; Time Factors | 1995 |
1-(2-Tetrahydrofuryl)-5-fluorouracil in combination with uracil suppresses mammary carcinogenesis and growth of tumors induced with 7,12-dimethylbenz[a]anthracene in rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Bromodeoxyuridine; Female; Hormones; Immunohistochemistry; Incidence; Mammary Neoplasms, Experimental; Organ Size; Rats; Rats, Sprague-Dawley; Tegafur; Thymidine Kinase; Thymidylate Synthase; Uracil | 1996 |